NKTR News

VITL INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Vital Farms (VITL) Investors of Securities Class Action Deadline on May 26, 2026 Ready to Announce with Confidence?

NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026 Ready to Announce with Confidence?

Pomerantz LLP Reports Filing of Class Action Litigation Against Nektar Therapeutics – NKTR

Deadline Alert: Nektar Therapeutics (NKTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit

Bronstein, Gewirtz & Grossman LLC Urges Nektar Therapeutics Investors to Act: Class Action Filed Alleging Investor Harm

NKTR Shareholder Alert: Nektar Therapeutics Securities Class Action Lawsuit – Investors Should Contact The Gross Law Firm

NKTR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Nektar Therapeutics Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Class Action Filing Announced by Pomerantz LLP Against Nektar Therapeutics – NKTR

Pomerantz Law Firm Announces The Filing of a Class Action Against Nektar Therapeutics, Inc. and Certain Officers - NKTR

Nektar Therapeutics Announces Closing of $373.8 Million Public Offering Including Full Exercise of Underwriters' Option to Purchase Additional Shares